Helpful strategies for establishing consistent nicotine patch use include staying motivated to use a nicotine patch, linking patch use to daily routines, and managing expectations of what a patch can do.
This tool presents detailed technical specifications for the set of quality measures identified and specified in a study of the link between improvements in processes of care for alcohol misuse and improvements in outcomes, known as the AQual study.
Using data from a follow-up sample (N = 491) and a community sample (N = 369) of adult daily and nondaily smokers, we replicated the findings from Edelen et al. (2014a) and examined the correlations of legacy smoking measures with the new item bank scores.
This tool reviews how primary care providers should discuss and treat alcohol or opioid dependence with their patients, including using extended-release, injectable naltrexone and administering buprenorphine/naloxone.
Brief Treatment for Substance Use Disorders: A Guide for Behavioral Health Providers is a clinician guidebook that describes a six-session brief treatment for patients with alcohol and opiate use disorders.
Increasing the number of physicians who can prescribe buprenorphine for opioid abuse and supporting their ability to treat more patients may be the fastest approach to enhancing capacity for treatment, particularly in less populated counties.
This study explores the experiences of peer mentors, all former smokers and persons with psychiatric illness, who provided smoking cessation counseling as part of a 6 month professionally-led intervention.
Sixty-seven people will die today in America because of heroin or narcotic painkillers, if recent overdose statistics are any guide. RAND research offers strategies to save those lives and thousands more around the world.
Up to 70% of homeless youth are smokers, smoking more than a half pack of cigarettes a day. Though there is strong demand for smoking-cessation services among this population and a willingness to help among providers, delivering these services remains a challenge.
Use of buprenorphine, a drug to treat opioid addiction, is increasing faster than the number of doctors licensed to dispense it. Policies focused on increasing the number of patients a qualified physician could treat may be more effective in addressing this increased use than other alternatives.
RAND researchers conducted a systematic review that synthesized evidence from trials of Mindfulness-Based Relapse Prevention (MBRP) to provide estimates of its efficacy and safety for treating substance use disorders.